APA (7th ed.) Citation

Kang, E. J., Hwang, S., Lee, Y., Choi, J., Shin, S. H., Choi, Y. H., . . . Kim, H. R. (2025). Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy. Cancer Research & Treatment, 57(3), 709. https://doi.org/10.4143/crt.2024.836

Chicago Style (17th ed.) Citation

Kang, Eun Joo, et al. "Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy." Cancer Research & Treatment 57, no. 3 (2025): 709. https://doi.org/10.4143/crt.2024.836.

MLA (9th ed.) Citation

Kang, Eun Joo, et al. "Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy." Cancer Research & Treatment, vol. 57, no. 3, 2025, p. 709, https://doi.org/10.4143/crt.2024.836.